Abstracts
Regular Abstracts to be presented at the conference
Late-Breaking/Clinical Trials Abstracts to be presented at the conference
RELEASE DATE FOR REGULAR, CLINICAL TRIAL, AND LATE-BREAKING ABSTRACTS
Regular, clinical trial, and late-breaking abstract titles and authors (no data) will be available on the AACR website on Monday, October 13, 2025, at 12 p.m. ET.
Regular abstracts (as outlined above) that are selected for presentation during the conference (poster or oral) will be released as a freely available supplement in the AACR journal Molecular Cancer Therapeutics and will be available in the conference app at 12 p.m. ET on Wednesday, October 22, 2025.
Clinical trial abstracts and late-breaking abstracts (as outlined above) that are selected for presentation during the conference (poster or oral) will be released in the conference app at 12 p.m. ET on Wednesday, October 22, 2025.
Abstracts will not be available before these dates.
Every effort will be made to reproduce the content of the abstracts as submitted, except in certain circumstances where changes may be made to comply with AACR style.
NOTIFICATION OF REGULAR, Late-Breaking, and Clinical Trial ABSTRACT STATUS
All individuals listed as abstract presenters of regular abstracts will be notified of acceptance or rejection by email approximately four (4) weeks after the July 21 abstract submission deadline. Notices and instructions will be sent to the email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting the AACR Meetings Department at [email protected].
All individuals listed as abstract presenters of late-breaking and clinical trial abstracts will be notified of acceptance or rejection by email approximately two (2) weeks after the September 10 abstract submission deadline. Notices and instructions will be sent to the email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting the AACR Meetings Department at [email protected].
All poster and oral presentations must be made in person.
changes and withdrawals
Any requests for changes to regular abstracts or withdrawals of regular abstracts must be sent to [email protected] by Friday, September 19, 2025, at 5 p.m. ET. Requests cannot be processed after this date. Therefore, abstract authors should carefully read their abstracts before submission to ensure that all authors are listed correctly and that the text is correct.
Any requests for changes to clinical trial or late-breaking abstracts or the withdrawal of a clinical trial or late-breaking abstract must be sent to [email protected] by Friday, October 3, 2025, at 12 p.m. ET. Requests cannot be processed after this date. Therefore, abstract authors should carefully read their abstracts before submission to ensure that all authors are listed correctly and that the text is correct.
REGISTRATION AND ACCOMMODATIONS FOR REGULAR, Late-Breaking, and Clinical Trial PRESENTERS
Individuals planning to present an abstract at this conference are encouraged to register and make a room reservation at one of the conference hotels as early as possible. If an abstract is not accepted for presentation at the conference, the presenter may request a full refund of the registration fee. For additional information, please visit the registration and accommodations and travel webpages.